Imperial College London will conduct a clinical trial with psilocybin-assisted therapy in the treatment of anorexia nervosa in adult women.
Clinical Trial – DMT-Assisted Therapy for Healthy Adults and Major Depressive Disorder (London/Manchester)
Small Pharma and Imperial College will conduct a clinical trial into the effects of DMT on Major Depressive Disorder. Both Healthy Volunteers and MDD patients will be included.
This open-label trial will investigate feasibility and efficacy of psilocybin-assisted psychotherapy for treatment-resistant depression.
30 volunteers who have tried a hallucinogen will take a single oral dose of Ibogaine in a clinical setting and stay for 6 nights in the clinic.
This feasibility study will assess the safety and obtain preliminary evidence for the efficacy of psilocybin-assisted physiotherapy for refractory motor Functional Neurological Disorder
This feasibility study will assess the safety and tolerability of conducting a physiotherapy regime designed for the treatment of motor Functional Neurological Disorder following administration of psilocybin in healthy volunteers
St Vincent’s Melbourne trial will see 40 patients receive psilocybin (the psychoactive compound in magic mushrooms) alongside a short program of psychotherapy and clinical support. The trial is for terminally ill patients who are experiencing depression or anxiety.
Researchers at Johns Hopkins are seeking individuals who have used breathwork to help with anxiety, depression, trauma, or PTSD symptoms to contribute to an anonymous web-based research survey.
HAVE YOU TAKEN PSYCHEDELIC MUSHROOMS DURING OR AFTER TREATMENT WITH AN ANTIDEPRESSANT? Learn More | Enrol The Johns Hopkins Center for Psychedelic and Consciousness Research is...
If you intend to take psilocybin, and are interested in contributing to the scientific understanding of the effects of psilocybin, we would like to...
12Page 1 of 2